| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.42 | 0.01 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |